← Back to Search

EnChroma glasses for Color Blindness

N/A
Waitlist Available
Led By Jeffrey Siegelman, MD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks post-intervention
Awards & highlights

Summary

This trial is testing whether EnChroma glasses can be used by healthcare providers who have trouble seeing colors. These glasses help by changing how light enters the eyes, making colors easier to see. The goal is to see if these glasses can help doctors and nurses better identify important color changes in patients. EnChroma glasses were designed to improve color vision among color-blind individuals, but studies show limited effectiveness.

Eligible Conditions
  • Color Blindness

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks post-intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Participants Reporting More Positive Than Negative Comments About the Use of the EnChroma Glasses
Overall Quality of Color Vision Perception Based on Patients' Description
Overall Quality of Color Vision Perception in Dim Light Based on Patients' Description
+1 more
Secondary study objectives
Number of Participants That Reported an Impact of Using the Glasses on Patient Care

Trial Design

1Treatment groups
Experimental Treatment
Group I: EnChroma glassesExperimental Treatment1 Intervention
EnChroma products improve brightness and color purity of primary colors for CVD people. Each participant with CVD will be provided EnChroma products to use indoors over the course of two weeks in the emergency department, educational settings, and in their personal life.

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,679 Previous Clinical Trials
2,583,660 Total Patients Enrolled
Jeffrey Siegelman, MDPrincipal InvestigatorEmory Univer
~1 spots leftby Sep 2025